As you make decisions about your cancer treatment, it can be helpful to understand what prior authorization is and how it can impact your care. Sometimes, prior authorization programs can be barriers to getting needed treatments. Keep reading to learn more, including what to do if your health insurance company denies a prior authorization request from your healthcare provider.

Have you ever arrived at a laboratory or pharmacy with your doctor's order for lab work or a prescription, only to be denied the test or your prescribed medication? Each insurance plan has different benefits and coverage guidelines. Benefit managers determine these guidelines. Keep reading to learn how laboratory and pharmacy benefit managers can impact your insurance benefits and coverage.

If your insurance provider denies a claim for medical services you’ve received, you have the right to file an appeal. The process of filing an appeal can seem daunting. But it is both your right and in your best interest to appeal a denied claim that you and your healthcare team deem important for your health. Keep reading for step-by-step guidance and tools to help you through the process.

High-deductible health plans (HDHPs) are an increasingly popular type of health plan, especially for employer-sponsored plans. This blog explains how these health plans work and certain risks they can pose for enrollees — particularly for those with a chronic health condition or serious illness, such as cancer.

On January 1, 2022, the No Surprises Act went into effect. This is a new law that protects patients from unexpected or “surprise” medical bills. Keep reading to learn about these new protections for patients.

The period to purchase 2022 health insurance coverage is open now through January 15, 2022. Read on to learn what you need to know to ensure that you and your loved ones have access to high-quality and affordable coverage.

On March 16, the Centers for Medicare & Medicaid Services announced that it would not move forward with proposed policy changes that would allow health plans to reduce their coverage of drugs in Medicare’s 6 “protected classes.” The Cancer Support Community applauds this decision, as this policy change would have had negative consequences for patients, including those impacted by cancer.

Clinical trials are a promising avenue for expanding treatment options and extending survival for people with cancer. However, out-of-pocket costs associated with trial participation and gaps in insurance coverage create barriers for many cancer patients. The CLINICAL TREATMENT Act guarantees coverage of the routine care costs of clinical trial participation for Medicaid enrollees with life-threatening conditions, like cancer.

Every year between October 15 and December 7, Medicare beneficiaries can make changes to their Medicare coverage. This “open enrollment” period provides an important opportunity for individuals over the age of 65 to review their Medicare coverage to determine if a different plan may better meet their needs. If a beneficiary decides that they do not want to make any changes, then no action is required. It may be helpful to think of open enrollment as an annual ‘check-up’ for Medicare coverage and benefits.